Stoke Therapeutics (STOK) Cash from Operations (2018 - 2026)
Stoke Therapeutics' quarterly Cash from Operations came in at 60582000.0 in Q1 2026, down 145.96% year-on-year from 131827000.0 in Q1 2025, and down 98.93% quarter-over-quarter from 30454000.0 in Q4 2025.
Stoke Therapeutics has reported Cash from Operations for 9 years, with the latest figure at 60582000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 145.96% year-over-year to 60582000.0; the trailing twelve-month figure through Mar 2026 stood at 146824000.0 (down 311.13% YoY), and the FY2025 full-year result was 45585000.0, up 152.49% from the prior year.
- Cash from Operations for Q1 2026 stood at 60582000.0, down from 30454000.0 in the prior quarter.
- The five-year high for Cash from Operations was 131827000.0 in Q1 2025, with the low at 60582000.0 in Q1 2026.
- Average Cash from Operations over 5 years is 12634176.47, with a median of 21800000.0 recorded in 2023.
- Year-over-year, Cash from Operations sank 165.73% in 2023 and jumped 636.62% in 2025.
- Tracing STOK's Cash from Operations over 5 years: stood at 22373000.0 in 2022, then rose by 7.71% to 20649000.0 in 2023, then retreated by 12.32% to 23193000.0 in 2024, then plunged by 31.31% to 30454000.0 in 2025, then plunged by 98.93% to 60582000.0 in 2026.
- The last three Cash from Operations figures came in at 60582000.0 (Q1 2026), 30454000.0 (Q4 2025), and 30366000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | -60.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.58 Mn |
| Mar 31, 2026 | -60.58 Mn |
| Dec 31, 2025 | -30.45 Mn |
| Dec 31, 2025 | -30.45 Mn |
| Sep 30, 2025 | -30.37 Mn |
| Sep 30, 2025 | -30.37 Mn |
| Jun 30, 2025 | -25.42 Mn |
| Jun 30, 2025 | -25.42 Mn |
| Mar 31, 2025 | 131.83 Mn |
| Mar 31, 2025 | 131.83 Mn |
| Dec 31, 2024 | -23.19 Mn |
| Dec 31, 2024 | -23.19 Mn |
| Sep 30, 2024 | -21.62 Mn |
| Sep 30, 2024 | -21.62 Mn |
| Jun 30, 2024 | -17.48 Mn |
| Jun 30, 2024 | -17.48 Mn |
| Mar 31, 2024 | -24.57 Mn |
| Mar 31, 2024 | -24.57 Mn |
| Dec 31, 2023 | -20.65 Mn |
| Dec 31, 2023 | -20.65 Mn |
| Sep 30, 2023 | -17.26 Mn |
| Sep 30, 2023 | -17.26 Mn |
| Jun 30, 2023 | -21.80 Mn |
| Jun 30, 2023 | -21.80 Mn |
| Mar 31, 2023 | -21.36 Mn |
| Mar 31, 2023 | -21.36 Mn |
| Dec 31, 2022 | -22.37 Mn |
| Dec 31, 2022 | -22.37 Mn |
| Sep 30, 2022 | -22.06 Mn |
| Sep 30, 2022 | -22.06 Mn |
| Jun 30, 2022 | -19.93 Mn |
| Jun 30, 2022 | -19.93 Mn |
| Mar 31, 2022 | 32.49 Mn |
| Mar 31, 2022 | 32.49 Mn |
| Dec 31, 2021 | -16.26 Mn |
| Dec 31, 2021 | -16.26 Mn |
| Sep 30, 2021 | -14.68 Mn |
| Sep 30, 2021 | -14.68 Mn |
| Jun 30, 2021 | -15.83 Mn |
| Jun 30, 2021 | -15.83 Mn |
| Mar 31, 2021 | -20.14 Mn |
| Mar 31, 2021 | -20.14 Mn |
| Dec 31, 2020 | -10.93 Mn |
| Dec 31, 2020 | -10.93 Mn |
| Sep 30, 2020 | -10.87 Mn |
| Sep 30, 2020 | -10.87 Mn |
| Jun 30, 2020 | -9.65 Mn |
| Jun 30, 2020 | -9.65 Mn |
| Mar 31, 2020 | -10.77 Mn |
| Mar 31, 2020 | -10.77 Mn |
| Dec 31, 2019 | -10.20 Mn |
| Dec 31, 2019 | -10.20 Mn |
| Sep 30, 2019 | -8.05 Mn |
| Sep 30, 2019 | -8.05 Mn |
| Jun 30, 2019 | -6.27 Mn |
| Jun 30, 2019 | -6.27 Mn |
| Mar 31, 2019 | -6.53 Mn |
| Mar 31, 2019 | -6.53 Mn |
| Dec 31, 2018 | -3.52 Mn |
| Dec 31, 2018 | -3.52 Mn |
| Sep 30, 2018 | -3.04 Mn |
| Sep 30, 2018 | -3.04 Mn |